Pegloticase (Krystexxa®, Savient Pharmaceuticals), a modified porcine enzyme, can produce significant and sustained clinical improvements in two out of five patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17 issue of Journal of American Medical Association. In two controlled clinical trials, pegloticase rapidly lowered high levels of uric [...]
Sep 28 2011 | Posted in
International |
Read More »
More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, reports a new study published in the journal Osteoporosis International. The study, which reviewed osteoporosis screening and management programmes in 11 countries, examined both randomised trials and clinical programmes involving patients treated for fragility fractures [...]
Sep 8 2011 | Posted in
International |
Read More »
Merck, known as MSD outside the United States and Canada, and Hanwha Chemical Corporation have entered into an exclusive global agreement to develop and commercialise HD203, a candidate biosimilar form of Enbrel® (etanercept) developed by Hanwha. Under the terms of the agreement, Merck will conduct clinical development and manufacture. In addition, upon marketing approval, Merck [...]
Generally healthy patients who undergo total hip replacement (THR) can be fast-tracked to be discharged in two days compared with the standard three to six days, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City. The prospective study compared outcomes of patients undergoing THR at HSS between [...]
Aug 17 2011 | Posted in
International |
Read More »
